WESTON, Fla., March 17 /PRNewswire-FirstCall/ -- American
Scientific Resources, Inc. (the "Company") (Pink Sheets:
ASFX), confirms today that it has received formal confirmation
and payment advice for the additional purchase of its Disintegrator
Needle Destruction Device from Bayer-Schering Pharmaceuticals.
The order requires the production and delivery of additional
units following the successful fulfillment and deployment of this
shipment purchased by Bayer Healthcare. American Scientific has
already begun manufacture of these and additional units to satisfy
follow-up orders.
Bayer Healthcare is one of the worlds leading pharmaceutical
companies and utilizes the Disintegrator by providing it to
patients who administer by injection its Betaferon medication.
Disintegrator units are manufactured with Bayer Healthcare
specific colors and logos, and are currently in daily use in
France.
Jason Roth, the Company's Senior
Vice President, commented, "We are pleased that we are continuing
with the Bayer Healthcare contract and look forward to the
additional stages of the contract. Bayer Healthcare represents a
world class partner for American Scientific and we look forward to
our continued relationship with them and with other customers and
users worldwide."
Dr. Chris Tirotta, CEO of
American Scientific, commented, "Again we have achieved another
significant milestone in our business plan – a business plan that
we continue to implement. We look forward to not only follow on
commitments from this contract but also fulfilling the other
opportunities we have out there."
In addition to the Bayer Healthcare Disintegrator and the
Disintegrator Plus, the Company is in late stage development
of a Non Government Organization (NGO) version designed to be taken
up globally by aid providers operating in areas where injections
and immunizations are key in the fight against disease. The
Disintegrator NGO provides foundations and aid organizations
a cost effective way of destroying harmful needles at the point of
use in developing countries worldwide. The Company is working on
this project with its partners in manufacturing and front line aid
providers.
According to the World Health Organization (WHO), it is
estimated that globally 16 Billion injections are administered
annually in developing and transitional countries alone. They
also indicate that each year unsafe injections cause an estimated
1.3 million early deaths, a loss of 26 million years of life, and
an annual burden of USD535 million in
direct medical costs.
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is both an operating company
and the holding company for wholly owned subsidiary, Kidz-Med. The
Company sources and designs innovative health and safety products,
develops intellectual property and distributes through established
relationships and channels both in-house and through its ever
growing network of proven global healthcare distributors.
For more information, visit the corporate web site at
www.americansci.com and the Company's subsidiary Kidz-Med at
www.kidzmed.com.
Safe Harbor
This release may contain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995.
Statements contained in this release that are not historical facts
may be deemed to be forward-looking statements. Investors are
cautioned that forward-looking statements are inherently uncertain.
Actual performance and results may differ materially from that
projected or suggested herein due to certain risks and
uncertainties including, without limitation, ability to obtain
financing and regulatory and shareholder approvals for anticipated
actions.
Contact
|
|
American Scientific
Resources Investor Relations
|
|
E-mail
IR@americansci.com
|
|
Or call
561-948-4863
|
|
|
SOURCE American Scientific Resources, Inc.